Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 January 2019 | Story Zama Feni | Photo Zama Feni
Sinoxolo Gcilitshane
Former UFS student and former Bloemfontein teacher, Sinoxolo Gcilitshane, received a Mandela Rhodes Scholarship to study further at the University of Cape Town.

The education career of a University of the Free State alumnus and budding teacher, Sinoxolo Gcilitshane, has been given a boost after he was granted a Mandela Rhodes Scholarship to do a Bachelor of Education Honours at the University of Cape Town this year.

This prestigious offer comes after only one year of teaching experience at Petunia Secondary School in Bloemfontein, where the 25-year-old first plied his trade as an educator in English and Social Sciences since January last year.

Gcilitshana, who holds a Bachelor of Education in Further Education and Training Phase from the University of the Free State, has since resigned from his teaching job.

His honours programme will focus on the teaching of History. “I chose this area simply because I still can’t believe the impact of my Grade 12 History teacher, the handsome Zimbabwean, Vimbai Muchabaiwa. His competency, commitment, and inspiring pedagogy really inspired me to such an extent that I decided that one day, I want to be like him, to teach like him, and love students in the same way he loves us.”

It is Gcilitshana’s resolute belief in himself that led to him receiving this esteemed opportunity. “There were those who told me that the Mandela Rhodes Scholarship is not for average students like me, and I believed them, because I couldn’t even speak proper English when I joined the UFS.”

“I never imagined myself as a beneficiary of this prestigious scholarship; nevertheless, I decided to brush aside any beliefs of self-doubt about myself. I then applied, and here I am today through the grace of our Almighty,” he said.

“My philosophy in life is that nobody owes you anything – not a job, not a greeting. It is therefore important for everyone, especially young people, to build their brand and to always chase excellence in all that they do – not money.

Asked where he would like to see himself in five years’ time, Gcilitshane, who was the Prime of Khayalami Residence once, brimmed with excitement when he said: “Within the next five years, I hope that I will be tasked with the responsibility and special privilege of teaching at a university anywhere in the country, where I will get the opportunity to work really hard and do my research and become one of the leading scholars in my field of specialisation.” He intends going for a master’s degree after finishing this programme.

 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept